Medtronic Boosts FY20 Adj. Earnings Outlook - Quick Facts

美美敦力(Medtronic)财政20年。盈利前景-快速事实

2019-08-21 02:38:04 RTTNews

本文共429个字,阅读需2分钟

While reporting financial results for the first quarter on Tuesday, Medtronic plc. raised its adjusted earnings guidance for the full-year 2020, while maintaining organic revenue growth outlook. "As a result of our first quarter outperformance and confidence in our outlook, we are raising our full year EPS guidance," said Omar Ishrak, Medtronic chairman and chief executive officer. For fiscal 2010, the company increased its adjusted earnings guidance to a new range of $5.54 to $5.60 per share from the prior range of $5.44 to $5.50 per share. This includes an estimated 10 cent negative impact from foreign exchange based on current rates. However, the company continues to project organic revenue growth of about 4 percent. At current exchange rates, revenue growth would be negatively affected by 0.8 to 1.2 percent. On average, analysts polled by Thomson Reuters expect the company to report earnings of $5.48 per share on revenue growth of 2.8 percent to $31.41 billion for the year. Analysts' estimates typically exclude special items. For comments and feedback contact: editorial@rttnews.com Business News
在周二公布第一季度财务业绩的同时,美美敦力(Medtronic)公司。提高了2020年全年经调整的盈利指引,同时保持了有机收入增长前景。 美美敦力(Medtronic)董事长兼首席执行官奥马尔•伊斯赫克( Omar Ishrak )表示:“由于我们第一季度的表现优于预期,以及对我们前景的信心,我们正在提高我们全年的 EPS 指引。” 2010财年,公司将调整后的盈利指引从先前的每股5.44美元上调至每股5.50美元,至每股5.54美元至5.60美元。这包括按当前汇率计算的估计10%的外汇负面影响。 然而,该公司继续预计有机收入增长约4%。按当前汇率计算,收入增长将受到0.8%至1.2%的负面影响。 汤森路透( Thomson Reuters )调查的分析师平均预计,该公司今年营收增长2.8%,至31.41亿美元,每股收益为5.48美元。分析师的估计通常不包括特殊项目。 有关意见和反馈,请联系: edition @ rttnews.com 商业新闻

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文